[ad_1]
A new “injection” of optimism in the battle against him coronavirus as a vaccine with almost 95% effectiveness announced the company Modern.
Impressive results were announced with the vaccine in phase 3 of tests.
The analysis, released Monday, is based on 30,000 volunteers, 95 of whom were confirmed carriers of the coronavirus. Half received the vaccine in two doses over 28 days and the rest received placebo.
Tests showed that the candidate vaccine was percentage effective 94.5%.
The company announced that it now plans to approach the relevant US regulatory authority, Mr. FDA, in order to seek urgent approval in the coming weeks.
Your results Modern join the encouraging findings that emerged last week from the clinical trials of another vaccine company, the companies Pfizer / BioNTech, which showed an efficiency of 90%.
However, the Moderna vaccine is not expected to be available. Outside the United States before the new year. The pharmaceutical industry stated that 20 million doses will be ready to travel to the US before the end of 2020 and expressed hope to build more 500,000,000 – 1,000,000,000 next year for global use.
“We will have a vaccine that can stop Covid-19,” Moderna president Stephen Hoge said in a telephone interview.
The Moderna vaccine is based on similar technology MRNA with BioNTECH, while it is expected to be further evaluated by the FDA.
The data also shows that there were 11 serious Covid infections during the trial, but none among those vaccinated.
“The overall effectiveness was remarkable … it’s a wonderful day,” said Tal Zak, Moderna’s medical director.
What do we not know yet?
Despite the good news, we still don’t know how long will have the immunity.
There is evidence that it offers some protection to older age groups, who are also the most vulnerable, but the data is incomplete.
Zak told the BBC that his data so far showed that the vaccine “It doesn’t seem to lose its power” with age.
Also, it is not known whether the vaccine simply prevents people from getting seriously ill or whether it also prevents them from transmitting the virus. All of these questions will affect how a coronavirus vaccine is used.
